169 related articles for article (PubMed ID: 21344542)
1. Nuclear targeted delivery of macromolecules to retina and cornea.
Binder C; Read SP; Cashman SM; Kumar-Singh R
J Gene Med; 2011 Mar; 13(3):158-70. PubMed ID: 21344542
[TBL] [Abstract][Full Text] [Related]
2. Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea.
Johnson LN; Cashman SM; Kumar-Singh R
Mol Ther; 2008 Jan; 16(1):107-14. PubMed ID: 17923842
[TBL] [Abstract][Full Text] [Related]
3. G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.
Leaderer D; Cashman SM; Kumar-Singh R
Exp Eye Res; 2016 Apr; 145():380-392. PubMed ID: 26923800
[TBL] [Abstract][Full Text] [Related]
4. Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin.
Johnson LN; Cashman SM; Read SP; Kumar-Singh R
Vision Res; 2010 Mar; 50(7):686-97. PubMed ID: 19733192
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable Nanoparticles Based on Pseudo-Proteins Show Promise as Carriers for Ophthalmic Drug Delivery.
Zhang W; Kantaria T; Zhang Y; Kantaria T; Kobauri S; Tugushi D; Brücher V; Katsarava R; Eter N; Heiduschka P
J Ocul Pharmacol Ther; 2020; 36(6):421-432. PubMed ID: 32639222
[No Abstract] [Full Text] [Related]
6. A poly(ethylene) glycolylated peptide for ocular delivery compacts DNA into nanoparticles for gene delivery to post-mitotic tissues in vivo.
Read SP; Cashman SM; Kumar-Singh R
J Gene Med; 2010 Jan; 12(1):86-96. PubMed ID: 19937991
[TBL] [Abstract][Full Text] [Related]
7. Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form.
Iwase Y; Kamei N; Khafagy el-S; Miyamoto M; Takeda-Morishita M
Int J Pharm; 2016 Aug; 510(1):304-10. PubMed ID: 27343364
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer.
Zhang Y; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
Mol Vis; 2003 Oct; 9():465-72. PubMed ID: 14551536
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.
Li W; Kong F; Li X; Dai X; Liu X; Zheng Q; Wu R; Zhou X; Lü F; Chang B; Li Q; Hauswirth WW; Qu J; Pang JJ
Mol Vis; 2009; 15():267-75. PubMed ID: 19190735
[TBL] [Abstract][Full Text] [Related]
10. G-quartet oligonucleotide mediated delivery of functional X-linked inhibitor of apoptosis protein into retinal cells following intravitreal injection.
Talreja D; Cashman SM; Dasari B; Kumar B; Kumar-Singh R
Exp Eye Res; 2018 Oct; 175():20-31. PubMed ID: 29864441
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo assessment of delivery of hydrophobic molecules and plasmid DNAs with PEO-PPO-PEO polymeric micelles on cornea.
Hsiao F; Huang PY; Aoyagi T; Chang SF; Liaw J
J Food Drug Anal; 2018 Apr; 26(2):869-878. PubMed ID: 29567259
[TBL] [Abstract][Full Text] [Related]
12. Non-viral delivery of chemically modified mRNA to the retina: Subretinal versus intravitreal administration.
Devoldere J; Peynshaert K; Dewitte H; Vanhove C; De Groef L; Moons L; Özcan SY; Dalkara D; De Smedt SC; Remaut K
J Control Release; 2019 Aug; 307():315-330. PubMed ID: 31265881
[TBL] [Abstract][Full Text] [Related]
13. Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection.
Derksen TA; Sauter SL; Davidson BL
J Gene Med; 2002; 4(5):463-9. PubMed ID: 12221638
[TBL] [Abstract][Full Text] [Related]
14. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
15. Rapid ocular angiogenic control via naked DNA delivery to cornea.
Stechschulte SU; Joussen AM; von Recum HA; Poulaki V; Moromizato Y; Yuan J; D'Amato RJ; Kuo C; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1975-9. PubMed ID: 11481260
[TBL] [Abstract][Full Text] [Related]
16. Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina.
Ding XQ; Quiambao AB; Fitzgerald JB; Cooper MJ; Conley SM; Naash MI
PLoS One; 2009 Oct; 4(10):e7410. PubMed ID: 19823583
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of rAAV2-mediated transgene expression in retina cells in vitro and in vivo by coadministration of low-dose chemotherapeutic drugs.
Zhang S; Wu J; Wu X; Xu P; Tian Y; Yi M; Liu X; Dong X; Wolf F; Li C; Huang Q
Invest Ophthalmol Vis Sci; 2012 May; 53(6):2675-84. PubMed ID: 22427581
[TBL] [Abstract][Full Text] [Related]
18. Delivery of nucleic acids, proteins, and nanoparticles by arginine-rich cell-penetrating peptides in rotifers.
Liu BR; Liou JS; Chen YJ; Huang YW; Lee HJ
Mar Biotechnol (NY); 2013 Oct; 15(5):584-95. PubMed ID: 23715807
[TBL] [Abstract][Full Text] [Related]
19. Gene transfer with liposomes to the intraocular tissues by different routes of administration.
Masuda I; Matsuo T; Yasuda T; Matsuo N
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1914-20. PubMed ID: 8759362
[TBL] [Abstract][Full Text] [Related]
20. POD nanoparticles expressing GDNF provide structural and functional rescue of light-induced retinal degeneration in an adult mouse.
Read SP; Cashman SM; Kumar-Singh R
Mol Ther; 2010 Nov; 18(11):1917-26. PubMed ID: 20700110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
